Dead Cat Bounce

Anonymous

Guest
http://seekingalpha.com/article/347...ells-2-potential-shorts-2-to-buy?source=yahoo

Hospira Inc. is a specialty pharmaceutical and medication delivery company. It develops, manufactures and markets products that help improve the safety and productivity of patient care. It is a leading player in specialty injectable pharmaceuticals and the largest standalone player in generic injectables.

HSP's market share has seen a steady decline ever since it received the warning letter to its Clayton and Rocky Mount facilities by FDA. Further, its McPherson facility also received six Form 483 observations in Jan 2012. In a recent call the company management said that it has extended its scheduled shutdown of Rocky Mount plant by a few more weeks. There is no further clarity on the timelines of the potential resolution of its manufacturing issues. These issues are expected to hamper its production severely directly impacting its top line growth in 2012. Hospira's shares have risen 26% after hitting its 52-week lows in December. I don't see any further upside likely in the near term and believe that this is just a dead cat bounce. I expect the stock to resume its downward trajectory soon.
 


















One of my favorite scenes is in a movie called Animal House. Kevin Bacon yelling "ALL IS WELL. REMAIN CALM!" just before being mobbed and run over. Maybe it is worth checking out for a laugh.


Or the Iraqi minister of information saying on t.v. on top of a building saying "no Americans are here". In the background you see our tanks rumbling down the street.
 












This may not come as a surprise, but the ongoing shortages of various prescription drugs - notably, injectables that are used to treat assorted cancers - are not only preventing patients from receiving timely or the most appropriate treatments, but patients are dying sooner than they would otherwise and tumors are recurring more often, according to a survey of oncologists.

“The consequences are real. The quality of cancer care has been materially impacted. It’s disheartening,” says Susan Schwartz McDonald, ceo of National Analysts Worldwide, a market research and consulting firm that queried 204 oncologists last month. “Unfortunately, the prevalence is not really surprising, because we know the shortages have been severe. But this really brings it home… And it’s particularly painful to think about the factors distorting what’s happening in the supply chain.”
 






This may not come as a surprise, but the ongoing shortages of various prescription drugs - notably, injectables that are used to treat assorted cancers - are not only preventing patients from receiving timely or the most appropriate treatments, but patients are dying sooner than they would otherwise and tumors are recurring more often, according to a survey of oncologists.

“The consequences are real. The quality of cancer care has been materially impacted. It’s disheartening,” says Susan Schwartz McDonald, ceo of National Analysts Worldwide, a market research and consulting firm that queried 204 oncologists last month. “Unfortunately, the prevalence is not really surprising, because we know the shortages have been severe. But this really brings it home… And it’s particularly painful to think about the factors distorting what’s happening in the supply chain.”

Not content with just stealing pension benefits and launching mass layoffs during the worst economy in decades, Hospira is now literally killing people.
 






Not content with just stealing pension benefits and launching mass layoffs during the worst economy in decades, Hospira is now literally killing people.

That is why the corporate officers, starting with Begley should be criminally prosecuted. They gutted the manufacturing facilities for personal gain.
 






Is there really a correlation between the cuts in the manufacturing plants at Hospira and the early deaths of patients who did not have needed oncology medications? That is a pretty heavy accusation.
 






Is there really a correlation between the cuts in the manufacturing plants at Hospira and the early deaths of patients who did not have needed oncology medications? That is a pretty heavy accusation.

I give you that the correlation is not perfect but it also isn't zero correlation if that helps you sleep at night. HSP provides these critical life saving drugs but cannot because of the greed and ineptitude that pervades its management.
 












Then how would you explain the shortages at the other generic injectable manufacturers?

The pay the same douchebags at the same management consulting firms millions for the same flawed strategic advice, all in the hopes of taking as much money in option payouts from their company whilst it is still their turn at the trough.

You could not actually prove that Hospira killed people to a court of law. However, what can be proven in a court of law and what is actually true are two very different things.

With most of your c-suiters thses days it's not what is right...it's what can we get away with.
 












That is very true. Didn't Chris Begley write a book on ethics? Who at Hospira was responsible for the cutbacks? Are any of those decision makers still with the company?

Tom Werner is still here...have a feeling that guys days as CFO are numbered despite the spiffy new hairstyle he is sporting these days. He is like trying to look grandfatherish in hpes that when he is lying about not recalling certain facts during the course of all the various shareholder lawsuits some juror may believe him.